Dudediligence.

Penumbra, Inc

PENNYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$301.0MSep ’24$315.5MDec ’24$324.1MMar ’25$339.5MJun ’25$354.7MSep ’25$385.4MDec ’25$374.8MMar ’26$390.0MJun ’26
Net income, by quarter
$29.5MSep ’24$33.7MDec ’24$39.2MMar ’25$45.3MJun ’25$45.9MSep ’25$47.3MDec ’25$32.6MMar ’26$34.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$747.6M$847.1M$1.06B$1.19B$1.40B
Gross profit$475.4M$535.2M$682.6M$755.0M$942.4M
Operating income−$7.5M$6.1M$73.6M$9.3M$189.2M
Net income$5.3M−$2.0M$91.0M$14.0M$177.7M
Operating cash flow$9.5M−$55.7M$97.3M$168.5M$238.7M
Free cash flow−$11.7M−$75.0M$82.1M$147.3M$174.9M
Cash$59.4M$69.9M$167.5M$324.4M$186.9M
Shares outstanding37.6M38.1M38.7M38.5M39.2M